Medical Director, Early-Stage Clinical Development

Role: Medical Director of Clinical Development supporting late-stage oncology programs targeting RAS-mutant cancers, with a focus on novel targeted therapies and potential regulatory submissions. Responsibilities: lead clinical science strategy and documentation, oversee trial design, data interpretation, and safety reviews; represent development plans within teams; manage complex, high-priority studies independently; mentor cross-functional teams; build relationships with investigators, regulators, and stakeholders; ensure compliance with GCP, ICH, FDA, EMA standards; contribute to regulatory interactions, including INDs and breakthroughs. Requirements: MD (preferably oncology training), 5+ years in clinical development within pharma/biotech or academia, with experience in early to late-phase oncology trials, data analysis, protocol development, and regulatory documents; strong knowledge of GxP and global regulatory requirements; leadership and mentoring skills, strategic thinking, excellent communication. Preferred: contributions to regulatory submissions, experience in oncology with RAS mutations, success in health authority interactions, and process improvements. High-Value: oncology (RAS pathway), late-stage development, regulatory engagement, cross-functional leadership, clinical trial design, and biometrics integration. Work Setup: onsite at Redwood City, CA, with a competitive salary range of $295,000 - $339,000 USD.